Rare diseases
Investigational molecules
Locations
4275 Executive Square Suite 950, 92037-9208, United States
Longboard Pharmaceuticals Inc. focuses on developmental and epileptic encephalopathies with studies aimed at seizure control in children and adults affected by severe early-onset epilepsy syndromes. Its research activity in this area centers on conditions marked by frequent motor seizures and substantial neurological impairment.
The sponsor’s clinical work in this field is directed toward therapeutic options for severe seizure disorders across multiple age groups and international research sites.
Longboard Pharmaceuticals Inc. runs clinical trials in conditions such as Epileptic encephalopathy, Severe myoclonic epilepsy of infancy, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumBelgiumBelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
